ABCA1- and ABCG1-mediated cholesterol transport out of brain into the CSF is impaired in AD (−73 and −33%, respectively) which would tend to increase brain cholesterol which in turn would affect Abeta/amyloid metabolism (Marchi et al., 2019; Figure 2). The gene discussed is APP; the disease is Alzheimer disease.